
Cardiac imaging AI company Heartflow raised $364 million from an upsized public stock offering, far exceeding expectations.
Key Details
- 1Heartflow is an imaging AI vendor specializing in noninvasive CT-based cardiac tests.
- 2The company raised $364 million from its IPO, up from the original $100 million target.
- 3Shares were sold at $19 each, with over 19 million shares issued.
- 4Heartflow uses CT data to generate personalized 3D models of coronary arteries.
- 5The company reported $126 million in revenue last year, growing 44% year-over-year.
- 6Estimated market opportunity for Heartflow's products exceeds $5 billion.
Why It Matters

Source
Radiology Business
Related News

AI Platform Triples Functional Independence in UK Stroke Patients
AI brain imaging software deployed by NHS has significantly improved stroke outcomes and functional independence rates in England.

AI in Breast Imaging Achieves High NPV but Raises Recall Rates
AI systems in breast imaging yield near-perfect negative predictive value but increase recall rates compared to radiologists, particularly for intermediate-risk classifications.

Specialized LLM for Radiology Reports Outperforms GPT-4o in Summarization Task
A fine-tuned, domain-specific LLM (LLM-RadSum) outperforms GPT-4o in accurately summarizing radiology reports across multiple patient demographics and modalities.